- Research works
- 2 fractional, all time
- Citations
- 9 5.5 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 15% world 28%
Not ranked overall: PellePharm (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does PellePharm (United States) publish most on?
By volume in 2022–2025: Genetic and rare skin diseases., Hedgehog Signaling Pathway Studies and Cancer and Skin Lesions.
- 1 Genetic and rare skin diseases. Genetics 0 works
- 2 Hedgehog Signaling Pathway Studies Molecular Biology 0 works
- 3 Cancer and Skin Lesions Dermatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
openly available15.4%not open84.6%
World: 28% of research is openly available.
with international co-authors38.5%domestic only61.5%
World: 19% is written across borders.
Other research institutions in Menlo Park
- SRI International
- SLAC National Accelerator Laboratory
- Stanford Synchrotron Radiation Lightsource
- Exponent (United States)
- Kavli Institute for Particle Astrophysics and Cosmology
- Meta (United States)
- Pacific Biosciences (United States)
- Linac Coherent Light Source
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.